Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesDiseases and Disorders of the Male Reproductive SystemDRG 716-other-male-reproductive-system-o-r-procedures-for-malignancy-without-cc-mcc
    Ask Trek AI about this page

    Other Male Reproductive System O.R. Procedures for Malignancy without CC/MCC: Inpatient Reimbursement Overview

    DRG 716 encompasses inpatient operating room procedures on the male reproductive system for malignant diagnoses without Complication or Comorbidity or Major Complication or Comorbidity. It defines the clinical scope for grouping and is used to determine standardized Medicare inpatient reimbursement for these surgical admissions.

    Customize your policy alerts

    Sign up for drg 716 policy alerts

    Get alerted when payer policies referencing 716 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 716 Overview

    DRG 716 covers other male reproductive system operating room procedures performed for malignancy when no Complication or Comorbidity or Major Complication or Comorbidity is present. Typical cases include surgical interventions on the prostate, testes, penis, or associated structures where the primary diagnosis is cancer but the inpatient stay is not complicated by significant comorbid conditions. This Diagnosis-Related Group matters for Medicare payment because it groups clinically similar surgical admissions to establish a standardized prospective payment. Hospitals use this grouping to assign inpatient claims and determine reimbursement under Medicare inpatient rules.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative surgical technique and complication-reduction trials focusing on operative approaches for malignant male reproductive organs (for example, testicular, penile, or scrotal malignancies) in patients without significant comorbidities. These studies compare minimally invasive vs open approaches, enhanced recovery protocols, or novel hemostatic and wound management strategies to reduce intraoperative blood loss, operative time, and immediate postoperative complications. Results are relevant to providers for optimizing surgical pathways and to payers because shorter stays and fewer complications can lower inpatient costs and readmission risk for this DRG.
    • Comparative effectiveness studies evaluating adjuvant therapy sequencing and short-term oncologic outcomes in patients undergoing primary operative management for male genitourinary cancers without CC/MCC. These trials enroll patients who have undergone definitive O.R. procedures to compare timing and necessity of adjunctive treatments (observation vs early systemic or localized adjuvant therapy) and measure recurrence rates, early functional outcomes, and need for additional inpatient care. Findings inform clinicians about balancing immediate postoperative recovery with oncologic control, and inform payers about downstream utilization and cost implications associated with different post-surgical management strategies.
    • Post-discharge functional recovery and quality-of-life cohort studies tracking early postoperative morbidity, wound complications, and short-term return-to-function in otherwise healthy patients treated surgically for malignant conditions of the male reproductive tract. These observational studies follow patients during the 30–90 day post-discharge window to quantify readmissions, emergency visits, pain management needs, and patient-reported outcomes related to urinary, sexual, and psychosocial function. Data are valuable to providers for targeting interventions that reduce early readmissions and to payers for understanding short-term resource use and opportunities to improve care coordination for this DRG.

    Related Codes

    707-MAJOR-MALE-PELVIC-PROCEDURES-WITH-CC-MCC

    Major Male Pelvic Procedures with CC/MCC: Inpatient Reimbursement Overview

    708-MAJOR-MALE-PELVIC-PROCEDURES-WITHOUT-CC-MCC

    Major Male Pelvic Procedures without CC/MCC: Inpatient Reimbursement Overview

    709-PENIS-PROCEDURES-WITH-CC-MCC

    Penis Procedures with CC/MCC: Inpatient Reimbursement Overview

    710-PENIS-PROCEDURES-WITHOUT-CC-MCC

    Penis Procedures without CC/MCC: Inpatient Reimbursement Overview

    711-TESTES-PROCEDURES-WITH-CC-MCC

    Testes Procedures with CC/MCC: Inpatient Reimbursement Overview

    712-TESTES-PROCEDURES-WITHOUT-CC-MCC

    Testes Procedures without CC/MCC: Inpatient Reimbursement Overview

    713-TRANSURETHRAL-PROSTATECTOMY-WITH-CC-MCC

    Transurethral Prostatectomy with CC/MCC: Inpatient Reimbursement Overview

    714-TRANSURETHRAL-PROSTATECTOMY-WITHOUT-CC-MCC

    Transurethral Prostatectomy without CC/MCC: Inpatient Reimbursement Overview

    715-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-FOR-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures for Malignancy with CC/MCC: Inpatient Reimbursement Overview

    717-OTHER-MALE-REPRODUCTIVE-SYSTEM-O-R-PROCEDURES-EXCEPT-MALIGNANCY-WITH-CC-MCC

    Other Male Reproductive System O.R. Procedures Except Malignancy with CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 20

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.